Tag
Novartis India Limited
8 articles
The lack of interest in tendering shares during Novartis India Limited's open offer signals a potential shift in investor sentiment regarding the company's future. Despite an independent directors' committee deeming the offer price of ₹860.64 per share fair, Axis Capital reported zero shares tendered on the first day, and preliminary data indicates no shares were received through either dematerialized or physical channels. This open offer is part of a broader transaction where Novartis AG is selling its 70.68% stake, and the absence of tendered shares could reflect uncertainty among public shareholders or an expectation of further developments. Investors should monitor the final outcome of the open offer and assess the implications for Novartis India's ownership structure and strategic direction.
Novartis India Open Offer Receives Nil Demat Tenders
Axis Capital discloses tender status for WaveRise-ChrysCapital open offer for 26% stake in Novartis India.
Zero equity shares tendered in dematerialized form as of June 24, 2026.
Only 182 physical sha
Novartis India Open Offer Receives Minimal Share Tender
Axis Capital discloses tender update for open offer to acquire 26% of Novartis India.
Zero equity shares tendered in demat form and 112 shares in physical form as of June 23, 2026.
Tendered shares rep
Novartis India Open Offer Receives Minimal Tender Response
Axis Capital discloses tender update for Novartis India open offer by WaveRise, ChrysCapital, and Two Infinity.
Zero equity shares tendered in demat form and only 10 physical shares received as of Jun
Novartis India Open Offer Receives Minimal Share Tender
• Axis Capital discloses tender status for Novartis India's 26% open offer by WaveRise and ChrysCapital.
• Zero equity shares tendered in dematerialized form as of June 18, 2026.
• Only 10 physical sh
Novartis India Open Offer Receives Zero Shares Tendered
Axis Capital discloses zero equity shares were tendered on June 17, 2026, in the open offer for Novartis India.
The open offer is for acquiring up to 26% of Novartis India's voting share capital from
Novartis India Open Offer Receives Zero Shares
Axis Capital discloses zero equity shares tendered on first day of Novartis India open offer.
No shares were received in both dematerialized and physical form by the offer's escrow and registrar.
The
Novartis India 26% Open Offer at ₹860.64/Share
Acquirers announce mandatory open offer for 26% of Novartis India shares at ₹860.64 per share.
Independent Directors Committee recommends the offer as fair per SEBI pricing regulations.
Tendering peri
Novartis AG Sells 70.68% Stake, No Encumbrance
Novartis AG discloses no encumbrance on its 1.75 crore equity shares in Novartis India as of March 31, 2026.
Reiterates its agreement to sell its entire 70.68% stake to three acquirers, as per the Feb